Home
Viking Global Investors reported a 6.8% stake in BridgeBio Pharma BBIO · 13,026,367 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 6.8%
- Last report
- 8.2% · filed 25/11/14
- Shares held
- 13,026,367 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Viking Global Investors
- Event date
- 26/02/12
- Filed
- 26/02/17
6.8% stake · −1.4pp from the last report
- Stake
- 6.8%
- Last report
- 8.2%
- Since last report
- −1.4pp
BridgeBio Pharma trades, last 26 weeks
What else happened in BridgeBio Pharma around then
Filed or reported within 30 days of the trade day · 01/13~03/14Viking Global Investors's other 5% stake reports
- Viking Global Investors
5% stakeRegal Rexnord
5% stakeRegal Rexnord
RRX
5.4% stake
3,578,745 sh
5.4% stake
Filed 09/16
- Viking Global Investors
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
2.5% stake
1,503,478 sh
2.5% stake
Filed 08/14
- Viking Global Investors
Full saleApple
Full saleApple
AAPL
est. $911.9M
3,593,057 sh
est. $911.9M
Reported 08/14
06/30 holdings
- Viking Global Investors
Full saleAlphabet
Full saleAlphabet
GOOGL
est. $689M
2,395,865 sh
est. $689M
Reported 08/14
06/30 holdings
- Viking Global Investors
SellTesla
SellTesla
TSLA
est. $818.4M
1,945,745 sh
est. $818.4M
Reported 08/14
06/30 holdings
